Cognitive therapy for patients with schizophrenia

摘要

Anthony Morrison and colleagues report cognitive therapy as a safe and effective treatment alternative to antipsychotic drugs for people with schizophrenia spectrum disorders.1 In view of the effect of such a claim in The Lancet, several issues impeding the clinical translation of the study demand clarification, starting with its heterogeneous population (mixed schizophrenia and attenuated psychotic symptoms) combined with the absence of crucial clinical information (eg, psychosis duration and number of admissions). Two additional major issues question its clinical relevance.